相关实验视频

Updated: Jun 7, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

肝细胞癌的CAR-T细胞疗法:当前的趋势和挑战

Yexin Zhou^1,2, Shanshan Wei³, Menghui Xu²

¹Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

Frontiers in immunology

|November 21, 2024

概括

化学抗原受体 (CAR) T细胞疗法显示出治疗肝细胞癌 (HCC) 的前景. 需要创新来克服挑战,并提高CAR T细胞在肝癌患者的疗效.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
细胞疗法细胞疗法

背景情况:

肝细胞癌 (HCC) 是一种普遍存在的癌症,其生存率不令人满意.
目前的治疗方法包括手术和全身疗法,需要新的方法.
化学抗原受体 (CAR) T细胞疗法是癌症治疗的一个有前途的进步.

研究的目的:

审查最近的研究结果和临床进展,用于CAR T细胞治疗HCC.
阐明CAR T细胞在肝癌中的治疗益处和挑战.
提供CAR T细胞免疫疗法对HCC的当前状态和未来前景的概述.

主要方法:

综合了最近的发现和临床进展.
阐明治疗效益和主要障碍.
分析当前状态和未来前景.

主要成果:

在临床前和临床研究中,CAR T细胞疗法在向HCC方面表现出显著的疗效.
潜在的目标包括GPC3,c-Met和NKG2D用于肝癌免疫治疗.
在T细胞贩运,克服免疫抑制和安全方面的创新对于提高疗效至关重要.

结论:

CAR T细胞疗法对HCC治疗具有显著的前景.
将CAR-T细胞应用于HCC等固体瘤的挑战需要进一步研究.
制造和克服瘤微环境的进步是更广泛应用的关键.

关键词:

抗原是一种抗原.仿真抗原受体T细胞的T细胞受体基因治疗的基因疗法肝细胞癌是肝细胞癌.免疫疗法免疫疗法

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...